Novel antibodies as anticancer agents
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/1210372.pdf
Reference246 articles.
1. Abastado JP, Darche S, Jouin H, Delarbre C, Gachelin G, Kourilsky P . (1989). A monoclonal antibody recognizes a subset of the H-2Dd mouse major class I antigens. Res Immunol 140: 581–594.
2. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF et al. (1998). Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95: 548–553.
3. Agus DB, Gordon MS, Taylor C, Natale RB, Karlan B, Mendelson DS et al. (2005). Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer. J Clin Oncol 23: 2534–2543.
4. Albanell J, Codony J, Rovira A, Mellado B, Gascon P . (2003). Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4. Adv Exp Med Biol 532: 253–268.
5. Alitalo K, Tammela T, Petrova TV . (2005). Lymphangiogenesis in development and human disease. Nature 438: 946–953.
Cited by 73 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring heterogeneous expression of beta-actin (ACTB) in bladder cancer by producing a monoclonal antibody 6D6;BMC Urology;2024-06-12
2. Protein engineering for natural product biosynthesis: expanding diversity for therapeutic applications;Journal of Bio-X Research;2023-06
3. Targeted cancer therapy: The future of drug combinations;Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies;2023
4. Cancer therapeutic drug guide;Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease;2023
5. Novel diamide derivatives: Synthesis, characterization, urease inhibition, antioxidant, antibacterial, and molecular docking studies;Journal of Molecular Structure;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3